Clinical trial of the efficacy of new S-1 schedule (administered 14days followed by 7 days rest) for metastatic or recurrent breast cancer
Phase 2
Recruiting
- Conditions
- brest cancer
- Registration Number
- JPRN-UMIN000011258
- Lead Sponsor
- Kobe Breast Cancer Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1)HER2 positive 2)allergy for the medicine of the protocol 3)active double cancer 4)brain metastasis which needs treatment or radiation therapy in an emergency 5)severe liver metastasis or Lung metastasis with dyspnea 6)with pleural effusion,ascitis,ericardial effusion which needs treatment in an emergency 7)active infection 8)interstitial pneumonia 9)HBV antigen positive 10)uncontoroled diabetes mellitus 11)mental disease 12)pregnant or nursing women ,women who like to be pregnant 13)with doctors decision for exclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival
- Secondary Outcome Measures
Name Time Method Overall survival Time to Treatment failure Response rate